MCA
ABBV icon

MSH Capital Advisors’s AbbVie ABBV Stock Holding History

MSH Capital Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.48M Buy
17,814
+5,144
+41% +$1.11M 0.78% 30
2026
Q1 		$2.76M Sell
12,670
-4,833
-28% -$1.07M 0.58% 46
2025
Q4 		$4M Buy
17,503
+8,934
+104% +$2.04M 0.85% 28
2025
Q3 		$1.98M Sell
8,569
-95
-1% -$19.3K 0.53% 57
2025
Q2 		$1.61M Sell
8,664
-77
-0.9% -$14.3K 0.46% 65
2025
Q1 		$1.83M Sell
8,741
-141
-2% -$27.4K 0.57% 53
2024
Q4 		$1.58M Sell
8,882
-314
-3% -$57.7K 0.5% 61
2024
Q3 		$1.82M Sell
9,196
-271
-3% -$50.6K 0.56% 58
2024
Q2 		$1.62M Sell
9,467
-210
-2% -$34.8K 0.54% 59
2024
Q1 		$1.76M Sell
9,677
-344
-3% -$59.3K 0.62% 54
2023
Q4 		$1.55M Sell
10,021
-381
-4% -$55.5K 0.58% 57
2023
Q3 		$1.55M Sell
10,402
-479
-4% -$70.3K 0.61% 54
2023
Q2 		$1.47M Buy
10,881
+234
+2% +$34.3K 0.54% 64
2023
Q1 		$1.7M Sell
10,647
-374
-3% -$57.2K 0.72% 44
2022
Q4 		$1.78M Sell
11,021
-78
-0.7% -$12K 0.8% 38
2022
Q3 		$1.49M Sell
11,099
-479
-4% -$68.7K 0.73% 47
2022
Q2 		$1.77M Buy
11,578
+356
+3% +$54.4K 0.82% 39
2022
Q1 		$1.82M Buy
11,222
+599
+6% +$87K 0.75% 41
2021
Q4 		$1.44M Buy
+10,623
New +$1.25M 0.64% 50

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

MSH Capital Advisors's ABBV Position: Q2 2026 in Review

MSH Capital Advisors increased its AbbVie (ABBV) stake by 41% in Q2 2026, buying an estimated $1.11M and bringing the position to 17,814 shares worth $4.48M. The position accounts for 0.78% of the portfolio, ranked #30.

MSH Capital Advisors first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • MSH Capital Advisors held 17,814 shares of AbbVie worth $4.48M as of Q2 2026.
  • MSH Capital Advisors bought 5,144 AbbVie shares in Q2 2026, an estimated $1.11M.
  • AbbVie made up 0.78% of MSH Capital Advisors's portfolio in Q2 2026, its #30 holding.
  • MSH Capital Advisors first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on MSH Capital Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.